US EditionKingston research tests microdosing psilocybin for anxiety
2 Articles
2 Articles
More and more people are looking for treatments to manage anxiety without relying exclusively on drugs. Among these therapies, EMDR, a method that began as a treatment for psychological trauma, is now presented as a possible tool for those who live with different types of anxiety.
Kingston research tests microdosing psilocybin for anxiety
Kingston researchers are leading Canada’s first Health Canada–approved clinical trial testing at-home psilocybin microdosing for anxiety.The study, led by Dr. Claudio Soares, a professor at the Queen’s Department of Psychiatry and director of the Centre for Psychedelic Health and Research at Providence Care, investigates whether very low doses of psilocybin—an active compound in so-called “magic mushrooms”—can safely reduce symptoms of generaliz…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
